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It is still controversial whether subclinical hypothyroid-
ism and euthyroidism affect blood pressure. The study
aimed to explore the relationship between different
levels of thyroid-stimulating hormone (TSH) and blood
pressure in the participants with subclinical hypo-
thyroidism and euthyroidism. A total of 1319 partici-
pants were administered a questionnaire survey, and
their blood pressure, height and body weight measure-
ments were taken. Blood samples were taken to test
serum TSH. FT3 and FT4 were further examined if TSH
was abnormal. Participants were divided into euthyroid
group and subclinical hypothyroidism group. Euthyroid
group was further divided into three groups: group A
(TSH 0.3–0.99mIUl
 1), group B (TSH 1.0–1.9mIUl
 1) and
group C (TSH 1.91–4.8mIUl
 1). Results showed that
different levels of serum TSH had no relation with
systolic blood pressure (SBP) and diastolic blood
pressure (DBP). The prevalence of hypertension in
subclinical hypothyroidism group was significantly
higher than euthyroid group in females (41.3 vs 25.6%,
Po0.05). The risk of hypertension in subclinical
hypothyroidism group was significantly higher than that
in the euthyroid group after adjusted for age, gender,
smoking status, HOMA-IR (homoeostasis model assess-
ment of insulin resistance) and body mass index (odds
ratio (OR)¼1.753, 95% confidence interval (CI) 1.067–
2.879, P¼0.027). This association was stronger in
females (OR¼3.545, 95% CI 1.576–7.975, P¼0.004), but
there was no statistical significance in males. Within
normal range of TSH, both SBP and DBP were similar
among the three groups. The prevalence and risk of
hypertension were also similar among the three groups.
In conclusion, the prevalence of hypertension in sub-
clinical hypothyroidism group was significantly higher
than in euthyroid group in females. Change of TSH in
normal range did not affect blood pressure.
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Introduction
Thyroid dysfunction, both hypo- and hyper-
thyroidism, may increase the risk of hypertension.
1,2
However, it is still controversial whether mild
thyroid dysfunction, such as subclinical hypothyr-
oidism and also euthyroidism, affect blood pressure.
Previous studies have found that hypertension had
existed in the patients with subclinical hypothyr-
oidism who are characterized as having high serum
thyroid-stimulating hormone (TSH) level and nor-
mal thyroid hormones.
3 Subclinical hypothyroidism
was an independent risk factor for atherosclerosis
and myocardial infarction in elderly women.
4
Recently, some researches
5–8 had investigated
cross-sectionally the relation between thyroid func-
tion and blood pressure. Some found that there
was a modest, but significant positive association
between serum TSH and blood pressure within the
normal serum TSH range,
5,6 but the Framingham
Heart Study investigators reported no correlation
between serum TSH and any of the thyroid hormone
levels in euthyroid participants.
8 This epidemiolo-
gical study explored the relation between different
levels of serum TSH and blood pressure in the
participants with subclinical hypothyroidism and
euthyroidism on the basis of cross-sectional epide-
miological survey.
Patients and methods
Participants
In 2007, a total of 1534 inhabitants, aged 18–85
years, of three communities in DaDong district,
Received 14 January 2009; revised 4 April 2009; accepted 20 April
2009; published online 25 June 2009
Correspondence: Professor Z Shan, Department of Endocrinology
and Metabolism and Institute of Endocrinology, The First
Affiliated Hospital of China Medical University, No. 155 Nanjing
Bei Street, Heping District, Shenyang, Liaoning 110001, PR China.
E-mail: shanzhongyan@hotmail.com
1These authors contributed equally to this work.
Journal of Human Hypertension (2010) 24, 134–138
& 2010 Macmillan Publishers Limited All rights reserved 0950-9240/10 $32.00
www.nature.com/jhh
JHH JHHOpen enShenyang city, participated in a stratified sample
survey on thyroid diseases and type 2 diabetes.
Exclusion criteria were (i) participants having a
personal history of thyroid disease or taking medi-
cation affecting thyroid function, such as thyroxine,
antithyroid drugs, glucocorticoid, antiepileptic and
contraceptive drugs etc.; (ii) pregnant women or
within the first year of postpartum period;
(iii) participants without important relevant infor-
mation; (iv) participants with diabetes, and treated
with oral hypoglycaemic drugs or with insulin;
(v) participants who were recently diagnosed with
hypothyroidism or hyperthyroidism in this investi-
gation; (vi) participants with hypertension who
had taken oral antihypertensive drugs in the past 4
weeks. Moreover, 14 participants with subclinical
hyperthyroidism were also excluded from the
study. Finally, 1319 participants were enrolled and
evaluated.
Methods
1. The questionnaire: The questionnaire included
general information, such as name, gender,
ethnicity, date of birth, address, identification
card number, educational qualification, profes-
sion, family income, telephone number, duration
of time living in DaDong district, history of
childbearing, status of medical insurance, invol-
vement in sports and their diet intake (including
state of iodine intake), history of smoking and
drinking, family history and personal history of
thyroid disorders and other diseases.
2. Measurement of blood pressure, height and body
weight: All the participants were made to rest for
at least 30min and then blood pressure of their
right arm was measured twice with a desk-model
sphygmomanometer with the participants in a
sitting position. There was a 3-min interval
between the two measurements for each partici-
pant, and then the mean value of the two
measurements was used. Height and body weight
were measured to calculate body mass index
(BMI). BMI¼body weight (kg)/height (m
2).
3. Blood sample collection: Fasting blood samples
were drawn for serum TSH, fasting plasma
glucose and insulin tests. Serum FT3 and FT4
were further examined if TSH was abnormal.
The Homoeostasis model assessment of insulin
resistance (HOMA-IR) was calculated using the
following formula: HOMA-IR¼fasting plasma
glucose (mmoll
 1) insulin (mIUl
 1)/22.5.
4. Assay: Serum TSH, FT3 and FT4 were tested with
super-sensitive chemiluminescence immuno-
assay (IMMULITE, Diagnostic Products Corpora-
tion, Los Angeles, CA, USA), plasma glucose was
tested with hexokinase law (the first Japanese
pharmaceutical kit, Kyoto, Japan), and insulin
with radioimmunoassay (Biotechnology Research
Institute of the North Port, Beijing, China). The
intra-assay coefficients of variation were o8%
and the inter-assay coefficients of variation were
o10%. The reference ranges of TSH, FT4 and
FT3 were 0.3–4.8mIUl
 1, 10.3–24.5 and 2.3–
6.3pmoll
 1, respectively.
5. Diagnostic Criteria: (1) Hypertension: SBPX
140mmHg and/or DBPX90mmHg under quies-
cent condition, or with previous history of hyper-
tension. (2) Hyperthyroidism: TSH o0.3mIUl
 1,
FT346.3 and/or FT4424.5pmoll
 1. Subclinical
hyperthyroidism: TSHo0.3mIUl
 1, FT3 and FT4
within the reference range. (3) Hypothyroidism:
TSH44.8mIUl
 1,F T 4 o10.3pmoll
 1. Subclinical
hypothyroidism: TSH44.8mIUl
 1, FT4 within the
reference range.
Statistical analyses
Data processing and statistical analysis were per-
formed by SPSS 11.5 software. w
2-test was used for
the analysis of counting data. The t-test and analysis
of variance were used for the analysis of quantitative
data. TSH and HOMA-IR were analysed after log
transformation was performed. Spearman’s rank-
related analysis and linear regression analysis were
used to evaluate the correlation of the factors. Risk
factors were analysed using logistic regression.
Level of significance was set to 5%.
Ethical aspects
Research protocols were approved by the medical
ethics committee of The First Affiliated Hospital,
China Medical University. All participants provided
a written informed consent after the research
protocols were carefully explained to them.
Results
The relationship between different serum TSH levels
and mean blood pressure
The baseline characteristics of 1319 participants
are shown in Table 1. After 115 patients who had
taken hypotensive drugs in the past 4 weeks were
excluded, using the Spearman’s rank-related corre-
lation analysis among the remaining 1204 persons,
we found that the levels of serum TSH were not
associated with either mean systolic blood pressure
(SBP) or diastolic blood pressure (DBP) (P40.05),
whereas age, gender, smoking status, HOMA-IR,
BMI were associated with both SBP and DBP
(P¼0.000). The multiple linear regression analysis
showed that levels of serum TSH still had no
relation with mean SBP and DBP, even after
adjustment for above factors (Table 2).
The previous findings of our research group
showed that the incidence of thyroid dysfunction
between serum TSH level of 1.0 and 1.9mIUl
 1 was
the lowest.
9 There were 1226 participants whose
serum TSH levels were within the reference range
(0.3–4.8mIUl
 1); after excluding 102 patients who
had taken hypotensive drugs in past 4 weeks, the
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A (TSH 0.3–0.99mIUl
 1, 211 individuals), group B
(TSH 1.0–1.9mIUl
 1, 430 individuals) and group C
(TSH 1.91–4.8mIUl
 1, 483 individuals). Using
variance analysis, both mean SBP and DBP were
shown to be similar among three groups after
adjusting for age, gender, smoking status, HOMA-
IR and BMI (Table 3).
Influence of different serum TSH levels on
hypertension prevalence
Of the 1319 participants, 433 patients had hyperten-
sion and 886 didnot. The prevalence of hyperten-
sion in subclinical hypothyroidism group was
significantly higher than that in euthyroid group in
females (41.3 vs 25.6%, Po0.05).
There were significant differences between hyper-
tensives and non-hypertensives in age (52.2±12.4
vs 41.2±12.5 years old), gender (female: 49.9 vs
68.5%), proportion of smokers (27.5 vs 22%),
HOMA-IR (3.0±1.5 vs 2.4±1.2) and BMI
(26.1±3.6 vs 23.4±3.4kgm
 2) (all Po0.05), which
suggested that these factors were associated with
hypertension. After adjusting for age, gender, smok-
ing status, HOMA-IR and BMI, logistic regression
analysis indicated that different serum TSH levels
remained independent risk factors for hypertension
(odds ratio (OR)¼1.324, 95% CI 1.033–1.697,
P¼0.027). The risk for hypertension in subclinical
hypothyroidism group was 1.753 times more than
that in euthyroid group (OR¼1.753, 95% CI 1.067–
2.879, P¼0.027), this association was stronger in
females (OR¼3.545, 95% CI 1.576–7.975, P¼0.004),
but there was no significant difference in males
(Table 4).
The prevalence of hypertension was similar
among groups A, B and C in euthyroid participants.
Logistic regression analysis showed that serum
TSH levels in normal range were not associated
with hypertension prevalence after adjusting for
age, gender, smoking status, HOMA-IR and BMI
(OR¼0.990, 95% CI 0.847–1.158, P¼0.903).
Discussion
The cross-sectional epidemiological investigation
indicated that there was no difference in mean
blood pressure between the subclinical hypothyr-
oidism group and euthyroid group. However, the
prevalence of hypertension in subclinical hypothyr-
oidism group was significantly higher than that in
the euthyroid group. This association was especially
stronger in females, and there was no statistical
significance in males.
Table 1 Baseline characteristics of participants
All Euthyroid Subclinical hypothyroidism
Number 1319 1226 93
Age (year) 44.8±13.5 44.7±13.6 46.2±12.8
Gender (female %) 60.6% 59.1% 80.6%
a
Smoking status (smoking %) 23.8% 25% 7.5%
a
HBP (%) 32.8% 32.3% 39.8%
SBP (mmHg) 126.9±21.1 126.7±20.9 130.2±23.9
DBP (mmHg) 80.7±12.0 80.7±11.9 80.4±12.6
TSH (mIUl
 1) 2.3±1.7 2.0±1.0 6.8±2.4
a
BMI (kgm
 2) 24.3±3.7 24.3±3.7 24.4±3.2
HOMA-IR 2.8±5.1 2.8±5.3 2.4±1.2
a
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HOMA-IR, homoeostasis model assessment of insulin resistance; SBP,
systolic blood pressure; TSH, thyroid-stimulating hormone.
aCompared with euthyroid group Po0.05.
Table 2 Multiple linear regression analysis of the relationship between serum TSH and SBP and DBP
SBP DBP
B s.e. P B s.e. P
Gender  10.304 1.149 0.000*  6.605 0.724 0.000*
Age 1.821 0.036 0.000* 0.109 0.023 0.000*
BMI 0.295 0.141 0.000* 0.911 0.089 0.000*
Smoking status  2.158 1.066 0.043*  1.324 0.672 0.049*
Lg(HOMA-IR) 4.677 2.008 0.020* 4.280 1.266 0.001*
Lg(TSH) 0.295 0.838 0.576 0.859 1.030 0.404
Abbreviations: B, regression coefficient; BMI, body mass index; DBP, diastolic blood pressure; HOMA-IR, homoeostasis model assessment of
insulin resistance; SBP, systolic blood pressure; s.e, standard error; TSH, thyroid-stimulating hormone.
*Po0.05.
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blood pressure. The increment of systemic vascular
resistance may be the main mechanism in clinical
hypothyroidism patients. T3 can directly act on
arterial smooth muscle cells of blood vessels to
cause vasodilation.
10 When hypothyroidism occurs,
declining T3 level increases the vascular resistance
and the level of blood pressure. Hypothyroidism can
also lead to the abnormality of sodium metabolism,
the sympathetic nervous system activity raising, and
the glomerular filtration rate decreasing etc., which
may be involved in the occurrence of hyperten-
sion.
6,11,12 Blood pressure salt sensitivity was also
one of the critical factors for hypertension in
hypothyroid patients.
13 The study of Gumieniak
et al.
6 showed that the relationship between FTI and
salt sensitivity is, in part, mediated by the vascular
action of thyroid hormone.
Recent researches indicated that cardiovascular
disorders had existed in the subclinical hypo-
thyroidism stage. Luboshitzky et al.
3 found that the
prevalence of hypertension in the subclinical
hypothyroidism group was significantly higher than
that in the normal control group, which coincided
with our conclusion. Rotterdam’s study showed
that subclinical hypothyroidism was an indepen-
dent risk factor for atherosclerosis and myocardial
infarction.
14 Blood hypercoagulability, blood viscos-
ity increment, lipid abnormalities presenting in
subclinical hypothyroidism patients could increase
the risk for atherosclerosis,
14 and these factors
may also be involved in pathogenesis, in which
the subclinical hypothyroidism affects the blood
pressure.
Recently, the fact whether the reference range of
serum TSH (0.3–4.8mIUl
 1) is a safe range was
doubted. When TSH was in the reference range,
there was a linear increase in SBP and DBP with the
increasing serum TSH levels, and the prevalence of
hypertension also increased.
5,14,15 The Whickham
study indicated that serum TSH 2.0mIUl
 1 was
considered as the upper limit of the safe range.
16
A prospective survey of our group found that the
incidence of thyroid dysfunction between serum
TSH level 1.0 and 1.9mIUl
 1 was the lowest. When
the serum TSH level was 41.9mIUl
 1, the inci-
dence of hypothyroidism increased, and when the
serum TSH level o1.0mIUl
 1, the incidence of
hyperthyroidism increased.
9 In present study, we
divided the participants with euthyroidism into
three groups according to the levels of serum TSH,
that is, TSH 0.3–0.99, 1.0–1.9 and 1.91–4.8mIUl
 1,
and the results showed that there were no associa-
tion between the serum TSH level within the normal
reference range with blood pressure. Roos et al.
7
studied the association between euthyroidism
and metabolic syndrome, they also did not
find any relationship between serum TSH level
and blood pressure. The serum TSH is the most
sensitive indicator for the change of thyroid func-
tion, so in this study, we only analysed the
association between the serum TSH levels and
blood pressure.
In conclusion, our investigation confirmed that
subclinical hypothyroidism could increase the risk
for hypertension prevalence. More prospective
studies should be performed to confirm the associa-
tion between euthyroidism and blood pressure. TSH
Table 3 The comparisons of SBP and DBP among euthyroid participants
Group TSH (mIUl
 1) Number (individuals) SBP (mmHg) DBP (mmHg)
A 0.3–0.99 211 124.7±19.0 79.6±11.7
B 1.0–1.9 430 123.8±17.7 81.0±11.8
C 1.91–4.8 483 123.9±19.2 79.5±11.4
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; HOMA-IR, homoeostasis model assessment of insulin resistance;
SBP, systolic blood pressure; TSH, thyroid-stimulating hormone.
Both SBP and DBP were adjusted for age, gender, smoking status, HOMA-IR and BMI.
Table 4 Comparison of risk for hypertension prevalence between different TSH level groups
TSH (mIUl
 1) N Hypertensives (%) OR 95% CI P
All 0.3–4.8 1226 396 (32.3)
44.8 93 37 (39.8) 1.753 1.067–2.879 0.027*
Male 0.3–4.8 502 211 (42.0)
44.8 18 6 (33.3) 0.776 0.255–2.361 0.655
Female 0.3–4.8 724 185 (25.6)
44.8 75 31 (41.3)* 3.545 1.576–7.975 0.004*
Abbreviations: CI, confidence interval; OR, odds ratio; TSH, thyroid-stimulating hormone.
Compared with the participants with TSH between 0.3 and 4.8mIUl
 1,* Po0.05.
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What is known about topic?
K The prevalence of hypertension in subclinical
hypothyroidism group was significantly higher than in
euthyroid group in females.
K Change of TSH in normal range did not affect blood pressure.
What this study adds
K This epidemiological study explored the relationship
between different levels of serum TSH and blood pressure in
the participants with subclinical hypothyroidism and
euthyroidism on the basis of cross-sectional epidemiological
survey.
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